Medirom Healthcare Technologies Inc. MRM
Nasdaq · XNAS · stock · Services-Personal Services
Chart by TradingView
5/9
Piotroski F — financial health
-0.97
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $8.3B | $6.8B | $7.0B | $5.4B | $3.3B |
| Gross profit | $2.2B | $1.6B | $1.9B | — | — |
| Operating income | -$18.1M | -$391.6M | $97.0M | -$470.6M | -$746.1M |
| Net income | $148.8M | $115.4M | $149.0M | -$990.7M | -$539.2M |
| Operating cash flow | -$1.3B | -$631.7M | -$685.7M | -$557.2M | -$366.4M |
| Free cash flow | -$1.4B | -$767.6M | -$806.4M | -$652.9M | -$440.0M |
| Total assets | $8.1B | $6.8B | $6.7B | $5.8B | $5.7B |
| Total liabilities | $6.9B | $6.6B | $6.8B | $6.0B | $5.2B |
| Shareholders' equity | $987.9M | $210.9M | -$59.4M | -$208.3M | $491.3M |
| Ratios | |||||
| Gross margin | 27.1% | 23.0% | 27.4% | — | — |
| Operating margin | -0.2% | -5.7% | 1.4% | -8.7% | -22.3% |
| Net margin | 1.8% | 1.7% | 2.1% | -18.3% | -16.1% |
| FCF margin | -16.9% | -11.2% | -11.6% | -12.1% | -13.2% |
| Return on assets | 1.8% | 1.7% | 2.2% | -17.2% | -9.4% |
| Return on equity | 15.1% | 54.7% | -250.9% | 475.5% | -109.8% |
| Debt / equity | 1.40× | 4.98× | -19.36× | -3.58× | 1.36× |
| Current ratio | 0.65 | 0.49 | 0.65 | 0.43 | 0.79 |
| Revenue growth | 21.5% | -1.8% | 28.5% | 61.9% | -14.5% |
Why these scores methodology →
Piotroski F-score: 5/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.97 (distress)
- Working capital / assets -0.182
- Retained earnings / assets 0.028
- EBIT / assets -0.002
- Equity / liabilities 0.143
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001819704 · as of 2024-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.